References

1. Ferlay J, Bray F, Pisani P, Parkin DM, 2001. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press, Version 1.0. IARC Cancer Base No.5.
2. Koutsky L, 1997. Epidemiology of genital human papillomavirus infection. Am J Med 102: 3–8.
   [Google Scholar]
3. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU, 2002. Proof of principle study investigators: a controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651.
   [Google Scholar]
4. Schiffman MH, 1992. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 84: 394–398.
   [Google Scholar]
5. Barnes RC, 1989. Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev 3: 119–136.
   [Google Scholar]
6. Center for Disease Control and Prevention, 1993. Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR Morbid Mortal Weekly Rep 42: 1–39.
   [Google Scholar]
7. Boom R, Sol CJA, Salimans MM, Jansen CL, van Wetheim PME, van der Noordaa J, 1990. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495–503.
   [Google Scholar]
8. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N, 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354.
   [Google Scholar]
9. Kleter B, van Doorn LJ, Schegget J, Schrauwen L, van Krimpen C, Burgear M, Harmsel B, Quint W, 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153: 1731–1739.
   [Google Scholar]
10. Melchers WJ, Bakkers JM, Wang J, de Wilde PCM, Boonstra H, Quint WGV, 1999. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 155: 1473–1478.
    [Google Scholar]
11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD, 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428.
    [Google Scholar]
12. Fife KH, Cramer HM, Schroeder JM, Brown DR, 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64: 550–559.
    [Google Scholar]
13. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ, 2000. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87: 221–227.
    [Google Scholar]
14. Ferrera A, Velema JP, Figueroa M, Bulnes R, Toro LA, Claros JM, Barahona O, Melchers WJG, 1999. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int J Cancer 82: 799–803.
    [Google Scholar]
15. Schachter J, Hill EC, King EB, Heilbron DC, Ray RM, Margolis AJ, Greenwood SA, 1982. Chlamydia trachomatis and cervical neoplasia. JAMA 248: 2134–2138.
    [Google Scholar]
16. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW, 2002. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324–331.
    [Google Scholar]
17. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, van den Brule AJ, Franceschi S, Peeling RW, 2004. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 111: 431–439.
    [Google Scholar]
18. Tamim H, Finan R, Sharida HE, Rashid M, Almawi WY, 2002. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43: 277–281.
    [Google Scholar]